Home / NYKD.OL : OSL

AI Analysis Fundamentals Valuation Earnings Video Analysis News Similar

AI Analysis

How does NYKD.OL make money? Does NYKD.OL have pricing power? What's the Earnings Whisper? Will NYKD.OL profit more as the business scales? What is NYKD.OL's management track record? Is NYKD.OL's current price justified?

Nykode Therapeutics AS

NOK 3.00 +$0.65 (+27.33%)

OSL · 30 Oct 2026 15:25 UTC

Previous Close

NOK 3.02

Day Range

NOK 2.94NOK 3.08

Year Range

NOK 2.06NOK 5.20

Market Cap

1.18B

AVG Volume

1.68M

Trailing/Forward PE

-4.69/65.54

PEG ratio

-0.05

Dividend Yield

Next Earnings Date

2026-11-25

Primary Exchange

Oslo Stock Exchange

Revenue (USD) · Q

NYKD.OL Revenue (USD) by quarter
Period	Revenue (USD)
26 Q2	106K
26 Q1	0
25 Q4	0
25 Q3	0
25 Q2	198K
25 Q1	137K
24 Q4	6.77M
24 Q3	536K
24 Q2	544K
24 Q1	827K

Net Income (USD) · Q

NYKD.OL Net Income (USD) by quarter
Period	Net Income (USD)
26 Q2	-7.18M
26 Q1	-4.1M
25 Q4	-8M
25 Q3	-3.66M
25 Q2	859K
25 Q1	-1.44M
24 Q4	-6.76M
24 Q3	-9.73M
24 Q2	-7.39M
24 Q1	-14.94M

Operating Income (USD) · Q

NYKD.OL Operating Income (USD) by quarter
Period	Operating Income (USD)
26 Q2	-6.94M
26 Q1	-6.71M
25 Q4	-8.09M
25 Q3	-6.28M
25 Q2	-6.68M
25 Q1	-7.54M
24 Q4	-5.99M
24 Q3	-14.95M
24 Q2	-11.79M
24 Q1	-15.6M

EBITDA · Q

Cash Flows · Q

EPS · Q

Expenses · Q

Cash & Debt · Q

Debt ratios · Q

Margins · Q

Return on Capital · Q

Shares Outstanding · Q

Dividends (USD) · Q

Employee Count

Book Value Per Share · Q

Total Assets · Q

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 25 Nov 2026.

No video analysis for this stock yet. Request one from our team.

AI Analysis

Nykode Therapeutics AS

Earnings: NYKD.OL

Video analysis: NYKD.OL

News: NYKD.OL

Similar companies